Tower Research Capital (TRC)’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-121
Closed -$3.06K – 6013
2026
Q2
$3.06K Buy
+121
New +$3.06K ﹤0.01% 4580
2026
Q1
– Sell
-1,146
Closed -$29.2K – 5302
2025
Q4
$29.2K Sell
1,146
-2,227
-66% -$56.7K ﹤0.01% 2826
2025
Q3
$86.1K Sell
3,373
-1,138
-25% -$28.9K ﹤0.01% 2123
2025
Q2
$115K Buy
4,511
+277
+7% +$6.98K ﹤0.01% 2266
2025
Q1
$107K Buy
+4,234
New +$106K ﹤0.01% 1738

Other funds holding IBDT

Tower Research Capital (TRC)'s IBDT Position: Q3 2026 in Review

Tower Research Capital (TRC) sold out of iShares iBonds Dec 2028 Term Corporate ETF (IBDT) in Q3 2026, closing a stake of 121 shares — an estimated $3.06K sold.

Tower Research Capital (TRC) first reported a position in IBDT in Q1 2025 and held it in 5 quarters. The position peaked at $115K in Q2 2025. 449 funds tracked by Wall St. Rank hold IBDT as of Q3 2026.

  • Tower Research Capital (TRC) reported no remaining iShares iBonds Dec 2028 Term Corporate ETF position as of Q3 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 121 iShares iBonds Dec 2028 Term Corporate ETF shares in Q3 2026, an estimated $3.06K.
  • Tower Research Capital (TRC) first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q1 2025 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s iShares iBonds Dec 2028 Term Corporate ETF position peaked at $115K in Q2 2025.
  • 449 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.